ALX Oncology
ALXO
#9346
Rank
โ‚น12.69 B
Marketcap
โ‚น98.22
Share price
3.92%
Change (1 day)
-23.34%
Change (1 year)

EPS for ALX Oncology (ALXO)

EPS in 2026 (TTM): -โ‚น102.36

According to ALX Oncology's latest financial reports the company's current EPS (TTM) is -โ‚น104.71. In 2025 the company made an earnings per share (EPS) of -โ‚น176.05 an increase over its 2024 EPS that were of -โ‚น240.92.

EPS history for ALX Oncology from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น102.36-41.86%
2025-โ‚น176.05-26.92%
2024-โ‚น240.92
2022-โ‚น280.7647.09%
2021-โ‚น190.8839.49%
2020-โ‚น136.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น125.09 19.47%๐Ÿ‡บ๐Ÿ‡ธ USA